Search

David Guzo

Examiner (ID: 10142)

Most Active Art Unit
1636
Art Unit(s)
2899, 1805, 1636
Total Applications
1205
Issued Applications
693
Pending Applications
160
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6918019 [patent_doc_number] => 20050095580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Method of determining adenovirus particle concentration' [patent_app_type] => utility [patent_app_number] => 10/505026 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5861 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095580.pdf [firstpage_image] =>[orig_patent_app_number] => 10505026 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505026
Method of determining adenovirus particle concentration Feb 13, 2003 Issued
Array ( [id] => 6710870 [patent_doc_number] => 20030170619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Nucleic acid capable of promoting gene expression' [patent_app_type] => new [patent_app_number] => 10/361849 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9150 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170619.pdf [firstpage_image] =>[orig_patent_app_number] => 10361849 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/361849
Nucleic acid capable of promoting gene expression Feb 10, 2003 Abandoned
Array ( [id] => 7149873 [patent_doc_number] => 20040171108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Human excitatory amino acid transporter-2 gene promoter and uses thereof' [patent_app_type] => new [patent_app_number] => 10/360349 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11404 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171108.pdf [firstpage_image] =>[orig_patent_app_number] => 10360349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/360349
Human excitatory amino acid transporter-2 gene promoter and uses thereof Feb 6, 2003 Abandoned
Array ( [id] => 6701602 [patent_doc_number] => 20030224482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same' [patent_app_type] => new [patent_app_number] => 10/360081 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15582 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224482.pdf [firstpage_image] =>[orig_patent_app_number] => 10360081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/360081
Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same Feb 5, 2003 Abandoned
Array ( [id] => 7355894 [patent_doc_number] => 20040013653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins' [patent_app_type] => new [patent_app_number] => 10/352839 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11050 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013653.pdf [firstpage_image] =>[orig_patent_app_number] => 10352839 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/352839
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins Jan 27, 2003 Issued
Array ( [id] => 6846859 [patent_doc_number] => 20030166026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Identification of specific biomarkers for breast cancer cells' [patent_app_type] => new [patent_app_number] => 10/339782 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34040 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166026.pdf [firstpage_image] =>[orig_patent_app_number] => 10339782 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339782
Identification of specific biomarkers for breast cancer cells Jan 7, 2003 Abandoned
Array ( [id] => 6829682 [patent_doc_number] => 20030180740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Differential expression screening method' [patent_app_type] => new [patent_app_number] => 10/204724 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30846 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180740.pdf [firstpage_image] =>[orig_patent_app_number] => 10204724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/204724
Differential expression screening method Jan 1, 2003 Abandoned
Array ( [id] => 6707777 [patent_doc_number] => 20030154511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Plant retroviral polynucleotides and methods for use thereof' [patent_app_type] => new [patent_app_number] => 10/334703 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 22932 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20030154511.pdf [firstpage_image] =>[orig_patent_app_number] => 10334703 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/334703
Plant retroviral polynucleotides and methods for use thereof Dec 19, 2002 Abandoned
Array ( [id] => 985395 [patent_doc_number] => 06924123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Lentiviral LTR-deleted vector' [patent_app_type] => utility [patent_app_number] => 10/324616 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9667 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924123.pdf [firstpage_image] =>[orig_patent_app_number] => 10324616 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/324616
Lentiviral LTR-deleted vector Dec 19, 2002 Issued
10/069623 Use of rafp to inhibit or prevent apoptosis Dec 15, 2002 Abandoned
Array ( [id] => 6740321 [patent_doc_number] => 20030157690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Fusion protein delivery system and uses thereof' [patent_app_type] => new [patent_app_number] => 10/306885 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12212 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157690.pdf [firstpage_image] =>[orig_patent_app_number] => 10306885 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/306885
Fusion protein delivery system and uses thereof Nov 26, 2002 Abandoned
Array ( [id] => 1173344 [patent_doc_number] => 06746690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'Process for producing composite preparation containing nucleic acid' [patent_app_type] => B2 [patent_app_number] => 10/294865 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5586 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/746/06746690.pdf [firstpage_image] =>[orig_patent_app_number] => 10294865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/294865
Process for producing composite preparation containing nucleic acid Nov 13, 2002 Issued
Array ( [id] => 7461769 [patent_doc_number] => 20040197895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Packaging lines for generation of high titers or recombinant aav vectors' [patent_app_type] => new [patent_app_number] => 10/415834 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20035 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197895.pdf [firstpage_image] =>[orig_patent_app_number] => 10415834 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/415834
Production of adeno-associated virus in insect cells Nov 7, 2002 Issued
Array ( [id] => 1040482 [patent_doc_number] => 06869780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-22 [patent_title] => 'Nodavirus-like DNA expression vector and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/230730 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10421 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869780.pdf [firstpage_image] =>[orig_patent_app_number] => 10230730 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/230730
Nodavirus-like DNA expression vector and uses therefor Nov 3, 2002 Issued
Array ( [id] => 6669397 [patent_doc_number] => 20030114381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Method of treating sensorineural hearing loss' [patent_app_type] => new [patent_app_number] => 10/274180 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8466 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114381.pdf [firstpage_image] =>[orig_patent_app_number] => 10274180 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/274180
Method of treating sensorineural hearing loss Oct 17, 2002 Abandoned
Array ( [id] => 7212319 [patent_doc_number] => 20050054105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Adenoviral vector system' [patent_app_type] => utility [patent_app_number] => 10/491936 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7919 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054105.pdf [firstpage_image] =>[orig_patent_app_number] => 10491936 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/491936
Adenoviral vector system Oct 3, 2002 Abandoned
Array ( [id] => 6869456 [patent_doc_number] => 20030082145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Adeno-associated virus materials and methods' [patent_app_type] => new [patent_app_number] => 10/263127 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7089 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082145.pdf [firstpage_image] =>[orig_patent_app_number] => 10263127 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/263127
Adeno-associated virus materials and methods Oct 1, 2002 Abandoned
Array ( [id] => 445698 [patent_doc_number] => 07252991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells' [patent_app_type] => utility [patent_app_number] => 10/260516 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 25796 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/252/07252991.pdf [firstpage_image] =>[orig_patent_app_number] => 10260516 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/260516
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells Sep 30, 2002 Issued
Array ( [id] => 6787715 [patent_doc_number] => 20030138954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Methods and compositions relating to restricted expression lentiviral vectors and their applications' [patent_app_type] => new [patent_app_number] => 10/261078 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26736 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138954.pdf [firstpage_image] =>[orig_patent_app_number] => 10261078 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/261078
Methods and compositions relating to restricted expression lentiviral vectors and their applications Sep 29, 2002 Issued
Array ( [id] => 7122431 [patent_doc_number] => 20050014260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Fusion protein delivery system and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/245475 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14136 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014260.pdf [firstpage_image] =>[orig_patent_app_number] => 10245475 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/245475
Fusion protein delivery system and uses thereof Sep 16, 2002 Issued
Menu